0001677995-21-000004.txt : 20210730 0001677995-21-000004.hdr.sgml : 20210730 20210730095323 ACCESSION NUMBER: 0001677995-21-000004 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210730 DATE AS OF CHANGE: 20210730 EFFECTIVENESS DATE: 20210730 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cerium Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001677995 IRS NUMBER: 454872095 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-408296 FILM NUMBER: 211130503 BUSINESS ADDRESS: STREET 1: 312 MAIN STREET STREET 2: SUITE 200 CITY: GAITHERSBURG STATE: MD ZIP: 20878 BUSINESS PHONE: 3019632400 MAIL ADDRESS: STREET 1: 312 MAIN STREET STREET 2: SUITE 200 CITY: GAITHERSBURG STATE: MD ZIP: 20878 D 1 primary_doc.xml X0708 D LIVE 0001677995 Cerium Pharmaceuticals, Inc. 312 MAIN STREET SUITE 200 GAITHERSBURG MD MARYLAND 20878 3019632400 DELAWARE None None Corporation true Gregg Lapointe 312 Main Street Suite 200 Gaithersburg MD MARYLAND 20878 Executive Officer Director Nancy Klett 312 Main Street Suite 200 Gaithersburg MD MARYLAND 20878 Executive Officer James Gale 312 Main Street Suite 200 Gaithersburg MD MARYLAND 20878 Director Thomas A DePasquale 312 Main Street Suite 200 Gaithersburg MD MARYLAND 20878 Director Biotechnology Decline to Disclose 06b false 2021-07-22 false true false 25000 10052959 8900000 1152959 false 5 0 0 0 false Cerium Pharmaceuticals, Inc. /s/ Gregg Lapointe Gregg Lapointe Chief Executive Officer 2021-07-30